TriangleNCT01676961 · OUTCOME
Percentage of Patients Who Have Responded
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- Not reported
- Unit
- Not reported
- Interval / dispersion
- Not reported
- Time frame
- 8 weeks
What was measured
Response is defined as platelet increases to greater than 50 x 10\^9/L for more than 2 weeks.
Analysis population: Data was not analyzed. Dr. Mazumder left institution and data was not analyzed.
Groups in this outcome
Supportive Care (Romiplostim)
Patients receive romiplostim SC once weekly for up to 6 weeks. Patients achieving a platelet count \> 50 x 10\^9 then receive romiplostim once weekly during 1 course of chemotherapy and may continue for as long as benefit is seen.. romiplostim: Given SC
| Group | Source count |
|---|---|
| Supportive Care (Romiplostim) | 0 |
Reported measurements
No numerical measurement classes were posted for this outcome. Missing is not zero.
Complete source fields
- denoms
- counts
- group Id
- OG000
- value
- 0
- units
- Participants
- description
- Response is defined as platelet increases to greater than 50 x 10\^9/L for more than 2 weeks.
- groups
- description
- Patients receive romiplostim SC once weekly for up to 6 weeks. Patients achieving a platelet count \> 50 x 10\^9 then receive romiplostim once weekly during 1 course of chemotherapy and may continue for as long as benefit is seen.. romiplostim: Given SC
- id
- OG000
- title
- Supportive Care (Romiplostim)
- population Description
- Data was not analyzed. Dr. Mazumder left institution and data was not analyzed.
- reporting Status
- POSTED
- time Frame
- 8 weeks
- title
- Percentage of Patients Who Have Responded
- type
- PRIMARY
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice